Cargando…

USF2-mediated upregulation of TXNRD1 contributes to hepatocellular carcinoma progression by activating Akt/mTOR signaling

Thioredoxin reductase 1 (TXNRD1) is one of the major redox regulators in mammalian cells, which has been reported to be involved in tumorigenesis. However, its roles and regulatory mechanism underlying the progression of HCC remains poorly understood. In this study, we demonstrated that TXNRD1 was s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Wen-ya, Liao, Zhi-bin, Zhang, Jia-cheng, Zhang, Xin, Zhang, Hong-wei, Liang, Hui-fang, Zhang, Zun-yi, Yang, Tao, Yu, Jia, Dong, Ke-shuai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9626593/ https://www.ncbi.nlm.nih.gov/pubmed/36319631 http://dx.doi.org/10.1038/s41419-022-05363-x

Ejemplares similares

USF1-ATRAP-PBX3 Axis Promote Breast Cancer Glycolysis and Malignant Phenotype by Activating AKT/mTOR Signaling
por: Wang, Dandan, et al.
Publicado: (2022)

TXNRD1 Is an Unfavorable Prognostic Factor for Patients with Hepatocellular Carcinoma
por: Fu, Binsheng, et al.
Publicado: (2017)

Mechanically activated ion channel Piezo1 contributes to melanoma malignant progression through AKT/mTOR signaling
por: Zhang, Simei, et al.
Publicado: (2022)

Upregulated UCA1 contributes to oxaliplatin resistance of hepatocellular carcinoma through inhibition of miR‐138‐5p and activation of AKT/mTOR signaling pathway
por: Huang, Guolin, et al.
Publicado: (2021)

xCT contributes to colorectal cancer tumorigenesis through upregulation of the MELK oncogene and activation of the AKT/mTOR cascade
por: Tang, Bufu, et al.
Publicado: (2022)

PRMT4 promotes hepatocellular carcinoma progression by activating AKT/mTOR signaling and indicates poor prognosis
por: Du, Peng, et al.
Publicado: (2021)

Zyxin promotes hepatocellular carcinoma progression via the activation of AKT/mTOR signaling pathway
por: CAI, TIANYING, et al.
Publicado: (2023)

PRMT4 promotes hepatocellular carcinoma progression by activating AKT/mTOR signaling and indicates poor prognosis: Erratum
por: Du, Peng, et al.
Publicado: (2022)

The Paradox of Akt-mTOR Interactions
por: Vadlakonda, Lakshmipathi, et al.
Publicado: (2013)

Upregulation of Superenhancer‐Driven LncRNA FASRL by USF1 Promotes De Novo Fatty Acid Biosynthesis to Exacerbate Hepatocellular Carcinoma
por: Peng, Jiang‐Yun, et al.
Publicado: (2022)

Targeting the PI3K/Akt/mTOR Pathway in Hepatocellular Carcinoma
por: Sun, Eun Jin, et al.
Publicado: (2021)

Aldose reductase interacts with AKT1 to augment hepatic AKT/mTOR signaling and promote hepatocarcinogenesis
por: Zhao, Jia-Xing, et al.
Publicado: (2017)

Alpha-synuclein contributes to malignant progression of human meningioma via the Akt/mTOR pathway
por: Ge, Yiqin, et al.
Publicado: (2016)

Inhibition of the AKT/mTOR pathway negatively regulates PTEN expression via miRNAs: Effect of Akt/mTOR inhibition on PTEN expression
por: Wan, Linyan, et al.
Publicado: (2022)

Downregulation of lncRNA OGFRP1 inhibits hepatocellular carcinoma progression by AKT/mTOR and Wnt/β-catenin signaling pathways
por: Chen, Wei, et al.
Publicado: (2018)

MYO18B promotes hepatocellular carcinoma progression by activating PI3K/AKT/mTOR signaling pathway
por: Zhang, Zhenyu, et al.
Publicado: (2018)

Regulation of Osteoclast Growth and Fusion by mTOR/raptor and mTOR/rictor/Akt
por: Tiedemann, Kerstin, et al.
Publicado: (2017)

Elevation of MAP17 enhances the malignant behavior of cells via the Akt/mTOR pathway in hepatocellular carcinoma
por: Chen, Xinhuang, et al.
Publicado: (2017)

The Roles of Autophagy, Mitophagy, and the Akt/mTOR Pathway in the Pathogenesis of Chronic Rhinosinusitis with Nasal Polyps
por: Wang, Chen, et al.
Publicado: (2022)

Upregulated TRIM29 promotes proliferation and metastasis of nasopharyngeal carcinoma via PTEN/AKT/mTOR signal pathway
por: Zhou, Xiao-Min, et al.
Publicado: (2016)

Combined targeting of AKT and mTOR synergistically inhibits proliferation of hepatocellular carcinoma cells
por: Grabinski, Nicole, et al.
Publicado: (2012)

Crocin induces autophagic apoptosis in hepatocellular carcinoma by inhibiting Akt/mTOR activity
por: Yao, Chong, et al.
Publicado: (2018)

The Role of PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma Metabolism
por: Tian, Ling-Yu, et al.
Publicado: (2023)

Targeting EGFR/PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma
por: Bang, Jieun, et al.
Publicado: (2023)

Mediator Complex Subunit 19 Promotes the Development of Hepatocellular Carcinoma by Regulating the AKT/mTOR Signaling Pathway
por: Zhang, Yuting, et al.
Publicado: (2022)

CD26 upregulates proliferation and invasion in keloid fibroblasts through an IGF-1-induced PI3K/AKT/mTOR pathway
por: Xin, Yu, et al.
Publicado: (2020)

Neuroinflammation and central PI3K/Akt/mTOR signal pathway contribute to bone cancer pain
por: Zhang, Jian, et al.
Publicado: (2019)

Elevated TRIP13 drives the AKT/mTOR pathway to induce the progression of hepatocellular carcinoma via interacting with ACTN4
por: Zhu, Meng-Xuan, et al.
Publicado: (2019)

Vertical Targeting of AKT and mTOR as Well as Dual Targeting of AKT and MEK Signaling Is Synergistic in Hepatocellular Carcinoma
por: Ewald, Florian, et al.
Publicado: (2015)

Rotundic Acid Induces DNA Damage and Cell Death in Hepatocellular Carcinoma Through AKT/mTOR and MAPK Pathways
por: Roy, Gaurab, et al.
Publicado: (2019)

Suppression of Akt-mTOR pathway rescued the social behavior in Cntnap2-deficient mice
por: Xing, Xiaoliang, et al.
Publicado: (2019)

EDG2 enhanced the progression of hepatocellular carcinoma by LPA/PI3K/AKT/ mTOR signaling
por: Xu, Meng, et al.
Publicado: (2017)

STAT3 or USF2 Contributes to HIF Target Gene Specificity
por: Pawlus, Matthew R., et al.
Publicado: (2013)

mTOR up-regulation of SNRPA1 contributes to hepatocellular carcinoma development
por: Feng, Jing, et al.
Publicado: (2020)

Hypoxia-mediated YTHDF2 overexpression promotes lung squamous cell carcinoma progression by activation of the mTOR/AKT axis
por: Xu, Peng, et al.
Publicado: (2022)

The Mitochondrial Deubiquitinase USP30 Regulates AKT/mTOR Signaling
por: Zhang, Ruohan, et al.
Publicado: (2022)

PI3K/AKT/mTOR pathway in pulmonary carcinoid tumours
por: Zhang, Zixuan, et al.
Publicado: (2017)

LncRNA‐LOC101928316 contributes to gastric cancer progression through regulating PI3K‐Akt‐mTOR signaling pathway
por: Li, Chengyun, et al.
Publicado: (2019)

M(6)A-mediated upregulation of HOXC10 promotes human hepatocellular carcinoma development through PTEN/AKT/mTOR signaling pathway
por: Li, Miao, et al.
Publicado: (2023)

Correction to: Elevated TRIP13 drives the AKT/mTOR pathway to induce the progression of hepatocellular carcinoma via interacting with ACTN4
por: Zhu, Meng-Xuan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9kmm5sc9n4pc8die2gpt2i979g